Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;30(4):398-405.
doi: 10.1111/ajad.13170. Epub 2021 Apr 28.

Development and Feasibility Study of an Addiction-Focused Phenotyping Assessment Battery

Affiliations

Development and Feasibility Study of an Addiction-Focused Phenotyping Assessment Battery

Lori A Keyser-Marcus et al. Am J Addict. 2021 Jul.

Abstract

Background and objectives: Current methods of classifying individuals with substance use disorder (SUD) result in vast heterogeneity among persons within a given diagnosis. These approaches, while clinically allowing for distinctions between patient groups, are less than ideal when attempting to recruit a neurobehaviorally defined subset of subjects into clinical trials. To address this gap, alternative strategies have been proposed, including behavioral phenotyping. The NIDA Phenotyping Assessment Battery (PhAB) is a modular package of assessments and neurocognitive tasks that was developed for use in clinical trials. The goal of the present study is to assess the feasibility of the NIDA PhAB with regard to ease of administration and time burden.

Methods: Healthy controls, persons with cocaine use disorder (CocUD), opioid use disorder (OUD), cannabis use disorder (CanUD), and combined opioid and cocaine use disorder (OCUD) were recruited from various sources (N = 595). Participants completed screening and one to three assessment visits. Time to complete the measures was recorded and a satisfaction interview was administered.

Results: Of the participants enrolled, 381 were deemed eligible. The majority of eligible participants (83%) completed all assessments. The average completion time was 3 hours. High participant satisfaction ratings were noted, with over 90% of participants endorsing a willingness to participate in a similar study and recommend the study to others. CONCLUSION AND SCIENTIFIC SIGNIFICANCE: These findings corroborate the ease with which the PhAB may be easily incorporated into a study assessment visit without undue participant burden. The PhAB is an efficient method for behavioral phenotyping in addiction clinical trials. (Am J Addict 2021;00:00-00).

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
NIDA phenotyping battery domains.
Figure 2.
Figure 2.
PhAB Feasibility study enrollment

References

    1. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22–57 - PubMed
    1. Mothi SS, Sudarshan M, Tandon N, et al. Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP). Schizophr Res. 2019;214:60–69. doi: 10.1016/j.schres.2018.04.037 - DOI - PubMed
    1. Williams LM. Defining biotypes for depression and anxiety based on large-scale circuit dysfunction: a theoretical review of the evidence and future directions for clinical translation. Depress Anxiety. 2017;34(1):9–24. doi: 10.1002/da.22556 - DOI - PMC - PubMed
    1. Latzman RD, DeYoung CG, HiTOP Neurobiological Foundations Workgroup. Using empirically-derived dimensional phenotypes to accelerate clinical neuroscience: The Hierarchical Taxonomy of Psychopathology (HiTOP) framework. Neuropsychopharm. 2020; 45, 1083–1085. doi: 10.1038/s41386-020-0639-6 - DOI - PMC - PubMed
    1. Cuthbert BN. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry. 2014;13(1):28–35. doi: 10.1002/wps.20087 - DOI - PMC - PubMed

Publication types